Stock Price
2.99
Daily Change
-0.66%
Yearly
-74.05%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Takeda 3,037.00 14.00 0.46% -22.11%
Daiichi Sankyo 2,834.00 -5.00 -0.18% -18.07%
Agios Pharmaceuticals 34.22 -0.61 -1.75% -23.45%
Alnylam Pharmaceuticals 171.36 -11.49 -6.28% 32.26%
Alexion Pharmaceuticals 182.50 0 0% 70.54%
Amgen 202.44 1.27 0.63% -11.68%
Arena Pharmaceuticals 49.55 -3.62 -6.81% -26.10%
Array Technologies Inc 16.87 -0.80 -4.53% -50.51%
Biogen 223.92 -4.60 -2.01% -8.93%
Bluebird Bio 9.95 -0.68 -6.40% -78.79%
BioMarin Pharmaceutical 82.95 -1.73 -2.04% 4.20%
Cerulean Pharma 1.78 0.09 5.33% 18.67%
Clovis Oncology 2.76 -0.35 -11.25% -47.92%
Esperion Therapeutics 5.25 -3.72 -41.47% -82.60%
Exelixis 15.84 -0.64 -3.88% -16.54%
Gilead Sciences 69.56 -0.11 -0.16% 13.00%
Glaxosmithkline 41.25 -0.22 -0.53% 10.00%
Intercept Pharmaceuticals 15.63 -1.41 -8.27% -55.85%
Incyte Corp 65.78 -0.85 -1.28% -20.88%
MacroGenics 16.40 -0.93 -5.37% -31.67%
Moderna Inc 306.72 5.23 1.73% 101.10%
Mirati Therapeutics 132.35 -4.71 -3.44% -43.26%
Novartis 73.57 -0.23 -0.31% -9.40%
Puma Biotechnology 2.99 -0.02 -0.66% -74.05%
Pfizer 54.27 1.23 2.32% 34.53%
PTC Therapeutics 35.36 -1.75 -4.72% -46.19%
Ultragenyx Pharmaceutical 76.01 -3.11 -3.93% -40.86%
Regeneron Pharmaceuticals 635.16 1.16 0.18% 28.98%
Roche Holding 362.25 -1.20 -0.33% 19.85%
Seattle Genetics 150.74 -7.93 -5.00% -15.90%
Sangamo BioSciences 8.10 -0.35 -4.14% -18.92%
Spectrum Pharmaceuticals 1.37 -0.21 -13.29% -71.87%
Sarepta Therapeutics 78.50 -4.69 -5.64% -50.36%
TG Therapeutics 15.64 -1.14 -6.79% -45.37%
Vanda Pharmaceuticals 16.22 -0.35 -2.11% 21.50%
Vertex Pharmaceuticals 203.81 -0.64 -0.31% -10.73%
Acceleron Pharma 178.75 -0.93 -0.52% 57.43%

Indexes Price Day Year
US2000 2159 -47.02 -2.13% 14.10%

Puma Biotechnology
Puma Biotechnology, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of products to improve cancer care. The Company's products include PB272 (neratinib, oral), PB272 (neratinib, intravenous), and PB357, as well as certain related compounds. Its lead product, NERLYNX, is an oral version of neratinib, which is a potent irreversible tyrosine kinase inhibitor (TKI), that blocks signal transduction through the human epidermal growth factor receptors, HER1, HER2 and HER4. Its initial focus is on the development of neratinib as an oral treatment for patients with HER2-positive metastatic breast cancer. Its product candidate, PB357, is an orally administered agent that is an irreversible TKI that blocks signal transduction through the epidermal growth factor receptors. The Company has two subsidiaries: Puma Biotechnology Ltd and Puma Biotechnology, B.V.